Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Ziprasidone in Schizophrenia
NCT00403546Phase 3Completed
- Start
- Jan 2006
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in schizophrenia, schizoaffective disorder. Started Jan 2006; status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00403546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403546.